Johnson & Johnson (JNJ) revealed that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has given its green light to a booster dose of the company's COVID-19 vaccine for individuals above 18 years of age. The company said that the request for emergency use authorization was approved with a unanimous vote of 19-0. The dose is supposed to be administered at least two months after the initial vaccination.
https://www.tipranks.com/news/johnson-johnsons-booster-dose-for-covid-19-gets-green-light?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Johnson and Johnson Charts.